- Home
- AOD vs ALVO Comparison
AOD vs ALVO Comparison
Compare AOD & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AOD | ALVO |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AOD | ALVO |
|---|---|---|
| Price | $10.62 | $5.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 399.2K | ★ 982.7K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.28 |
| Revenue Next Year | N/A | $18.63 |
| P/E Ratio | ★ N/A | $18.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.76 | $2.94 |
| 52 Week High | $10.85 | $9.25 |
Technical Indicators
Market Signals| Indicator | AOD | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 52.33 | 78.72 |
| Support Level | $10.23 | $4.46 |
| Resistance Level | $10.79 | $5.85 |
| Average True Range (ATR) | 0.10 | 0.28 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 51.38 | 100.00 |
Price Performance
Historical ComparisonAbout AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.